022san News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 022san. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 022san Today - Breaking & Trending Today

Travere Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Sparsentan for the Treatment of IgA Nephropathy

Published: May 16, 2022

PDUFA target action date of November 17, 2022SAN DIEGO, May 16, 2022 -- Travere Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted and granted Priority Review... | May 16, 2022

Source: marketscreener.com

Related Topics:

United StatesDeric DubeChris ClineExchange CommissionDrug AdministrationEurope UnionTravere Therapeutics IncInvestor Relations Corporate CommunicationsPriority ReviewNew Drug ApplicationPrescription Drug User Fee ActAbout IgaDual Endothelin Angiotensin Receptor AntagonistOrphan Drug DesignationTravere TherapeuticsPrivate Securities Litigation Reform ActVice PresidentInvestor RelationsNc Stock ExchangePress ReleaseRiority Tvtx Us89422g1076